<http://schema.org/articleBody>
"\n\tAdvertisement - Continue Reading Below\n\t\n\n\n\nWhen Angelina Jolie dropped her double mastectomy bombshell, one interesting detail that came to light was that the cost for testing for BRCA1 and BRCA2 genes is grossly expensive because only one company is allowed to do it. (Jolie had acknowledged that the cost of her own testing, over $3000, is out of reach for most mere Muggles.) This all makes sense because breast cancer kills no one and early prevention is NOT key. Turns out that we weren't the only ones who thought that seemed like stinky bullsh*t: The Supreme Court ruled unanimously yesterday that Myriad Genetics can't hold a patent for the breast cancer gene\u2014more specifically, that the whole idea of patenting genes makes zero sense because our bodies, like, invented them\u2014essentially removing the barrier that prohibited other companies from developing their own genetic tests. Now that the playing field has been leveled, more companies will develop BRCA1 and BRCA2 tests, and the prices will drop.Since legal cases about genetics are still so new\u2014next level, sci fi stuff\u2014the Supreme Court's ruling is a pretty big deal. It's also a pretty big deal that so soon after a high-profile woman came forward with her own brave personal decision to get tested, cost-prohibitive roadblocks for the rest of us disappeared. Basically, now that one company doesn't have a monopoly on the test (and ability to charge whatever the hell they want), it should end up costing way less than $3k. Angelina for the win. PS: We're still dyyyyying over this pic  of how gorge Angelina looked in her first post-mastectomy appearance. Click here for more on BRCA1 and whether you should get tested. Elisa is Cosmo's social media editor. Follower her on Twitter @elisabenson.Photo:  PacificCoastNews.com"^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.cosmopolitan.com/entertainment/celebs/news/a13287/supreme-court-breast-cancer-ruling/?click=cos_new>